Premium
Corticobasal Syndrome in a Family with Early‐Onset Alzheimer's Disease Linked to a Presenilin‐1 Gene Mutation
Author(s) -
Navarro Eloisa,
De Andrés Clara,
Guerrero Carmen,
GiménezRoldán Santiago
Publication year - 2015
Publication title -
movement disorders clinical practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.754
H-Index - 18
ISSN - 2330-1619
DOI - 10.1002/mdc3.12212
Subject(s) - neuropathology , presenilin , family history , disease , dementia , neuroimaging , neuropsychology , early onset alzheimer's disease , medicine , alzheimer's disease , psychology , neuroscience , genetics , pathology , biology , cognition
Background Alzheimer's disease ( AD ) is the second‐most frequent cause underlying corticobasal syndrome ( CBS ). However, a reliable diagnosis using clinical, neuropsychological, or neuroimaging approaches has not yet been achieved. Methods Clinical, neuropsychological, imaging, and neuropathology studies were undertaken in a large Spanish family with early‐onset familial AD ( EOFAD ) carrying a Met233Leu mutation linked to presenilin‐1 gene ( PSEN ‐1). Results Two of three examined members of this family presented with the usual amnestic pattern. At the age of 47 years, a third family member, in whom pathology was later confirmed, developed prominent CBS combined with severe neuropsychiatric and behavioral disturbances resembling those often found in EOFAD . Conclusion Although CBS in EOFAD appears to be rare, demonstration of a linkage to PSEN ‐1 gene mutations may permit in vivo diagnosis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom